CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Lynch Casey Chief Executive Officer | Grant or award · Stock Option (right to buy) | +440,000 | 440,000 | ||
| 2021-11-18 | Lynch Casey Chief Executive Officer | Exercise or conversion | +60,000 | $0.46 | $28K | 109,895 |
| 2021-11-18 | Lynch Casey Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −60,000 | 23,159 | ||
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −13,584 | $33.75 | $458K | 995,190 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −9,918 | $34.89 | $346K | 985,272 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −6,315 | $35.81 | $226K | 978,957 |
| 2021-05-10 | Lynch Casey Chief Executive Officer | Sale | −183 | $36.73 | $7K | 978,774 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −11,211 | $35.10 | $394K | 1,027,563 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −18,089 | $35.85 | $648K | 1,009,474 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −300 | $36.58 | $11K | 1,009,174 |
| 2021-03-22 | Lynch Casey Chief Executive Officer | Sale | −400 | $36.60 | $15K | 1,008,774 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −400 | $37.39 | $15K | 1,058,374 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,600 | $38.64 | $62K | 1,056,774 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −856 | $39.82 | $34K | 1,055,918 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −2,000 | $40.84 | $82K | 1,053,918 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −3,100 | $41.91 | $130K | 1,050,818 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,512 | $43.10 | $65K | 1,049,306 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −1,900 | $44.22 | $84K | 1,047,406 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −8,032 | $45.00 | $361K | 1,039,374 |
| 2021-02-03 | Lynch Casey Chief Executive Officer | Sale | −600 | $45.73 | $27K | 1,038,774 |
Page 1 of 2 · 31 trades